Press Release
Annual Information Update
Lilly (Eli) & Co
24 January 2013
Eli Lilly and Company
(the "Company")
Annual Information Update for the 12 months up to and including
22 February 2011.
This Annual Information Update refers to information that has been published or
made available to the public in European Economic Area states and in third
countries in compliance with the Company's obligations under EU and national
laws and rules dealing with the regulation of securities, issuers of securities
and securities markets. The Company is obliged to provide this Annual
Information Update by virtue of having transferable securities listed or
admitted to trading on regulated markets in London.
Neither the Company, nor any other person, takes any responsibility for, or
makes any representation, express or implied, as to the accuracy or
completeness of, the information which this Annual Information Update contains.
This information is not necessarily up to date as at the date of this Annual
Information Update and the Company does not undertake any obligation to update
any such information in the future. Furthermore, such information may have been
prepared in accordance with the laws or regulations of a particular
jurisdiction and may not comply with or meet the relevant standards of
disclosure in any other jurisdiction. This Annual Information Update does not
constitute an offer of any securities addressed to any person and should not be
relied on by any person.
1. FILINGS IN THE UNITED
KINGDOM
The following documents have been filed with the National Storage Mechanism:
Filing Date Description
11 February 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly
Announces Senior Leadership Changes
3 February 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co Necitumumab
Trial DMC
27 January 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly Reports
Fourth-Quarter and Full-Year 2010 Results
25 January 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co President of
Lilly Oncology Announces Resignation
21 January 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co FDA AdComm
Recommendation for Lilly and Avid's Amyvid
13 January 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co Liprotamase
FDA AdComm Negative Outcome
11 January 2011 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly and
Boehringer Ingelheim-Strategic Alliance
31 December 2010 Eli Lilly and Company - Issuer Document - Annual Report
(excluding RNA)
31 December 2010 Eli Lilly and Company - Issuer Document - Annual Report
(excluding RNA)
31 December 2010 Eli Lilly and Company -
E05765：イーライ・リリー・アンド・カンパニー S00083UO
：有価証券報告書 - Annual Report (excluding RNA)
23 December 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co BYETTA + basal
sNDA submitted to FDA
21 December 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Acquisition(s)
- Acquisition
14 December 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly Declares
First-Quarter 2011 Dividend
14 December 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co LILLY SUSPENDS
PHASE III TRIAL IN METASTATIC MELANOMA
24 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly and
Acrux Receive FDA Approval for Axiron
17 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Statement re
Byetta Study - Statement re
16 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Data Presented
for Patients Treated with Effient®
16 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co U.S. District
Court Confirms Validity of Alimta Patent
8 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly to
Acquire Avid Radiopharmaceuticals
5 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Cymbalta
Chronic Pain FDA Approval
2 November 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co LLY To Open
Diabetes-Focused Research Center in China
21 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly Reports
Third Quarter 2010 Results
21 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co MacroGenics &
Lilly's Clinical Trial of Teplizumab
20 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Bydureon
Complete Response
19 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Dividend
Declaration - Dividend Declaration
15 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Forteo Evista
Data
11 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Lilly Presents
New Data in Head and Neck Cancer
5 October 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co LLY Sets Date
for Q3 2010 Financial Results Announcement
29 September 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Form 8.3 -
Silence Therapeutics plc
21 September 2010 Eli Lilly and Company- DJ Lilly (Eli) & Co Jeffrey Winton
Named Vice President of Communications
15 September 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co EASD Curtain
Raiser Release
13 September 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Statement re
Class Certification Reversed - Statement re
1 September 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Court of
Appeals Upholds Validity of LLY Evista Patents
20 August 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Statement re
Cymbalta Medial Statement - Statement re
17 August 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co Research
Update - Research Update
13 August 2010 Eli Lilly and Company - DJ Lilly (Eli) & Co US Court Rules
Against Lilly on Strattera Patent
14 May 2010 Eli Lilly and Company - Issuer Document - Annual Report
(excluding RNA)
9 March 2010 Eli Lilly and Company - Issuer Document - Annual Report
(excluding RNA)
26 February 2010 Eli Lilly and Company - Issuer Document - Prospectus
(excluding RNA)
22 February 2010 Eli Lilly and Company - Issuer Document - Annual Report
(excluding RNA)
Full details of the above filings can be found on the National
Storage Mechanism's website at
http://www.morningstar.co.uk/uk/NSM.
2. FILINGS IN THE UNITED
STATES
The Company also submitted the following filings with the United
States Securities and Exchange Commission ("SEC") in compliance
with its obligations under national laws and rules dealing with the
regulation of securities, issuers of securities and securities
markets by virtue of having securities registered under the U.S.
Securities Exchange Act 1934:
Filing Date Forms Description SEC Filing
Group
22 February 2011 3 Initial statement of beneficial 3,4,5
ownership of securities
22 February 2011 10-K Annual report which provides a Annual
comprehensive overview of the company Filings
for the past year
17 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
17 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
14 February 2011 SC 13G/A Statement of acquisition of SC 13
beneficial ownership by individuals
(Amendment)
14 February 2011 SC 13G/A Statement of acquisition of SC 13
beneficial ownership by individuals
(Amendment)
14 February 2011 SC 13G/A Statement of acquisition of SC 13
beneficial ownership by individuals
(Amendment)
10 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
4 February 2011 PRE 14A Other preliminary proxy statements Proxy
Statement
4 February 2011 SC 13G Statement of acquisition of SC 13
beneficial ownership by individuals
3 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
3 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
3 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
3 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
3 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
3 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
2 February 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
31 January 2011 5 Annual statement of changes in 3,4,5
beneficial ownership of securities
31 January 2011 5 Annual statement of changes in 3,4,5
beneficial ownership of securities
31 January 2011 5 Annual statement of changes in 3,4,5
beneficial ownership of securities
31 January 2011 5 Annual statement of changes in 3,4,5
beneficial ownership of securities
31 January 2011 5 Annual statement of changes in 3,4,5
beneficial ownership of securities
31 January 2011 5 Annual statement of changes in 3,4,5
beneficial ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
27 January 2011 8-K Report of unscheduled material events Current
or corporate event Reports
19 January 2011 UPLOAD SEC-generated letter Other
18 January 2011 4 Statement of changes in beneficial 3,4,5
ownership of securities
20 December 2010 CORRESP Correspondence Other
17 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
1 December 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
17 November 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
9 November 2010 CORRESP Correspondence Other
29 October 2010 10-Q Quarterly report which provides a Quarterly
continuing view of a company's Filings
financial position
21 October 2010 8-K Report of unscheduled material events Current
or corporate event Reports
20 October 2010 CORRESP Correspondence Other
19 October 2010 CORRESP Correspondence Other
19 October 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
19 October 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
13 October 2010 UPLOAD SEC-generated letter Other
17 September 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
13 September 2010 SC 13G Statement of acquisition of SC 13
beneficial ownership by individuals
28 August 2010 CORRESP Correspondence Other
20 August 2010 CORRESP Correspondence Other
18 August 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
2 August 2010 10-Q Quarterly report which provides a Quarterly
continuing view of a company's Filings
financial position (Amendment)
30 July 2010 CORRESP Correspondence Other
30 July 2010 10-Q Quarterly report which provides a Quarterly
continuing view of a company's Filings
financial position
27 July 2010 UPLOAD SEC-generated letter Other
22 July 2010 8-K Report of unscheduled material events Current
or corporate event Reports
12 July 2010 CORRESP Correspondence Other
2 July 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
16 June 2010 CORRESP Correspondence Other
9 June 2010 CORRESP Correspondence Other
8 June 2010 UPLOAD SEC-generated letter Other
4 June 2010 3/A Initial statement of beneficial 3,4,5
ownership of securities (Amendment)
30 April 2010 10-Q Quarterly report which provides a Quarterly
continuing view of a company's Filings
financial position
19 April 2010 8-K Report of unscheduled material events Current
or corporate event Reports
19 April 2010 8-K Report of unscheduled material events Current
or corporate event Reports
15 March 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
12 March 2010 ARS Annual Report to Security Holders Annual
Filings
8 March 2010 DEFA14A Additional definitive proxy Proxy
soliciting materials and Rule 14(a) Statements
(12) material
8 March 2010 DEF 14A Other definitive proxy statements Proxy
Statements
3 March 2010 4 Statement of changes in beneficial 3,4,5
ownership of securities
26 February 2010 S-3ASR Automatic shelf registration Other
statement of securities of well-known
seasoned issuers
Full details of the above regulatory announcements can be found
on the SEC website at http://www.sec.gov.
CONTACT:
Jamie E. Haney
Counsel - Corporate Securities and Assistant Secretary
(317) 277-3278
(317) 407-1288 (M)
haney_jamie_e@lilly.com
LONDONAVINCE23599249.01
7
1233319-v2NYCDMS
LONDONAVINCE23599249.01